Ertl IE, Lemberger U, Rajwa P, Petrov P, et al. Low SMARCD3 expression is associated with poor prognosis in patients with prostate cancer. Prostate 2024 Oct 23. doi: 10.1002/pros.24815.
PMID: 39442954